publication venue for
- Comparing Injectable DaxibotulinumtoxinA and OnabotulinumtoxinA in Moderate and Severe Glabellar Lines: Additional Analyses From a Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Study. 43:S262-S273. 2017
- Injectable DaxibotulinumtoxinA for the Treatment of Glabellar Lines: A Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Comparison With OnabotulinumtoxinA and Placebo. 43:1321-1331. 2017
- Intravascular Basal Cell Carcinoma. 42:123-124. 2016
- Subject Satisfaction With OnabotulinumtoxinA Treatment of Glabellar and Lateral Canthal Lines Using a New Patient-Reported Outcome Measure. 41:950-959. 2015
- Acne Scar Treatment with Subcision Using a 20-G Cataract Blade. 37:846-847. 2011
- A Common Tumor, An Uncommon Location: Basal Cell Carcinoma of the Nipple and Areola in a 49-Year-Old Woman. 31:480-483. 2005
- Dermatologic Surgery Practice and Skin Cancer Treatment in Canada: Results of a National Survey. 31:27-32. 2005
- The Australian Polidocanol (Aethoxysklerol) Study. 21:334-336. 1995